299919-79-2
299919-79-2
Chemical Structure
SARS-CoV-2-IN-33
- CAS No.: 299919-79-2
- Formula:C30H30N4O5
- Molecular Weight:526.58
IUPAC Name: 4,4'-((3,4,5-trimethoxyphenyl)methylene)bis(3-methyl-1-phenyl-1H-pyrazol-5-ol)
InChIKey: KUOWSCYCAAGCPB-UHFFFAOYSA-N
SMILES: OC1=C(C(C2=C(N(C3=CC=CC=C3)N=C2C)O)C4=CC(OC)=C(C(OC)=C4)OC)C(C)=NN1C5=CC=CC=C5
Biological Activity: SARS-CoV-2-IN-33 (compound 3m) is a COVID-19 inhibitor. SARS-CoV-2-IN-33 shows anti-proliferative activity against cancer cells. SARS-CoV-2-IN-33 exhibits comparatively good binding affinity (-8.0 Kcal/mole) to COVID-19 main protease (Mpro) (PDB ID: 6LU7). SARS-CoV-2-IN-33 can be used in studies of cancer and COVID-19[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SARS-CoV-2-IN-33 | 99.02% | SARS-CoV-2-IN-33 (compound 3m) is a COVID-19 inhibitor. SARS-CoV-2-IN-33 shows anti-proliferative activity against cancer cells. SARS-CoV-2-IN-33 exhibits comparatively good binding affinity (-8.0 Kcal/mole) to COVID-19 main protease (Mpro) (PDB ID: 6LU7). SARS-CoV-2-IN-33 can be used in studies of cancer and COVID-19. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
